All Posts
FDA’s Flexible Requirements for Cell and Gene Therapy: CMC & Supply Chain Impact (Episode 1)
The FDA’s January 2026 announcement on “Flexible Requirements for Cell and Gene Therapies” has sent
February 12, 2026
The FDA’s January 2026 announcement on “Flexible Requirements for Cell and Gene Therapies” has sent
Start building reliable, high-quality drug development programs today.